FdaApplication
NDA 021763
Identifiers
- fda_app_no: NDA021763
Properties
| Property | Value |
|---|---|
| applicant_name | BIOVAIL LABORATORIES INTERNATIONAL SRL |
| application_type | NDA |
| approval_date | 2005-12-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | 40MG | TABLET;ORALLY DISINTEGRATING |
4 products